Your Article Summary
Effect of Short-term Dutasteride Therapy on Prostate Vascularity in Patients With Benign Prostatic Hyperplasia: A Pilot Study
Urology, 07/01/09
Kravchick S et al. - Six weeks of dutasteride treatment may reduce prostate tissue vascularity in the periurethral area proximal to the verumontanum. Preoperative treatment with dutasteride could improve operative performance and avoid TUR syndrome.
Related Articles
The Effect of Dutasteride on the Efficacy of Photoselective Vaporization of the Prostate: Results of a Randomized, Placebo-controlled, Double-blind Study (DOP Trial)
Urology, 10/08/09
Relevance Score: 90%
Effect of the dual 5alpha-reductase inhibitor, dutasteride, on serum testosterone and body mass index in men with benign prostatic hyperplasia
BJU International, 10/01/09
Relevance Score: 84%
Phase II Study of Androgen Synthesis Inhibition with Ketoconazole, Hydrocortisone, and Dutasteride in Asymptomatic Castration-Resistant Prostate Cancer
Clinical Cancer Research, 11/09/09
Relevance Score: 83%
Avodart (dutasteride) Regulatory Update
GlaxoSmithKline, 10/02/09
Relevance Score: 80%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Treatment with alpha-lipoic acid reduces asymmetric dimethylarginine in patients with type 2 diabetes mellitus
Translational Research, The Journal of Laboratory and Clinical Medicine, 12/11/09
Aripiprazole in the Treatment of Irritability in Children and Adolescents With Autistic Disorder
Pediatrics, 12/11/09
Emerging technologies in the delivery of erythropoietin for therapeutics
Medicinal Research Reviews, 12/11/09

See Latest Articles